The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines
- PMID: 8604953
The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines
Abstract
A group of experts from gastroenterology, internal medicine, health economics, medical outcomes, and managed care met in San Francisco, Calif, on September 27, 1994, in an effort to develop clinically and economically effective disease management guidelines to assist physicians in their treatment of gastroesophageal reflux disease in a managed care environment. This article represents a consensus opinion based on the evidence and expert interpretation at the time of that meeting.
Similar articles
-
Medical treatment of gastroesophageal reflux disease in the managed care environment.Semin Gastrointest Dis. 1997 Apr;8(2):90-9. Semin Gastrointest Dis. 1997. PMID: 9109696
-
Recommendations for best practices in the treatment of Alzheimer's disease in managed care.Am J Geriatr Pharmacother. 2006;4 Suppl A:S9-S24; quiz S25-S28. doi: 10.1016/j.amjopharm.2006.10.001. Am J Geriatr Pharmacother. 2006. PMID: 17157793
-
Treatment of gastroesophageal reflux disease in a managed care environment. Based on a presentation by Kevin Ashby, MD.Am J Manag Care. 2000 May;6(9 Suppl):S480-3. Am J Manag Care. 2000. PMID: 10977488
-
Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Based on a presentation by Kenneth R. DeVault, MD, FACG.Am J Manag Care. 2000 May;6(9 Suppl):S476-9. Am J Manag Care. 2000. PMID: 10977487 Review.
-
Managed care issues in the treatment of gastroesophageal reflux disease.Am J Manag Care. 2000 Oct;6(16 Suppl):S871-5. Am J Manag Care. 2000. PMID: 11184657 Review.
Cited by
-
The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review.Pharmacoeconomics. 2003;21(11):769-90. doi: 10.2165/00019053-200321110-00002. Pharmacoeconomics. 2003. PMID: 12859219 Review.
-
Gastroesophageal reflux disease: clinical features.Pharm World Sci. 2005 Dec;27(6):417-20. doi: 10.1007/s11096-005-7116-5. Pharm World Sci. 2005. PMID: 16341946
-
Lansoprazole for maintenance of remission of erosive oesophagitis.Drugs. 2002;62(8):1173-84. doi: 10.2165/00003495-200262080-00004. Drugs. 2002. PMID: 12010078 Review.
-
Dietary guideline adherence for gastroesophageal reflux disease.BMC Gastroenterol. 2014 Aug 14;14:144. doi: 10.1186/1471-230X-14-144. BMC Gastroenterol. 2014. PMID: 25125219 Free PMC article.
-
Cost effectiveness of competing strategies to prevent or treat GORD-related dysphagia.Pharmacoeconomics. 2000 Apr;17(4):391-401. doi: 10.2165/00019053-200017040-00009. Pharmacoeconomics. 2000. PMID: 10947494
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous